Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Start-Up Quarterly Statistics, Q3 2012

Nov 26 2012

• By Deanna Kamienski

Related Content

Sunovion To Purchase Elevation And Phase II Drug/Device Combo For COPD

Aug 31 2012

Aerpio Obtains $27M In Series A To Fund Pair Of Phase II Studies

Aug 30 2012

Verastem Catapults To Mid-stage Development with Pfizer Licensing Deal

Jul 12 2012

GenKyoTex, PsiOxus Raise VC Funding In Europe To Reach Phase II POC

Jul 09 2012

Third Rock Ventures Pumps $38 Million Into New Firm Focused On Genetic Heart Disease

Sep 20 2012

Related Companies

NantWorks, LLC

NantWorks, LLC

Liminal BioSciences Inc.

Liminal BioSciences Inc.

Relypsa, Inc.

Pfizer Inc.

MyoKardia, Inc.

Stanford University

University of Colorado

Harvard University

Harvard University

Aerpio Pharmaceuticals, Inc.

Akebia Therapeutics, Inc.

Roche Holding AG

Genentech, Inc.

Akamis Bio

Millendo Therapeutics, Inc.

Merck KGaA

Prexton Therapeutics

Valcare Medical, Ltd.

MiCardia

Avinger, Inc.

BioTelemetry, Inc.

Foundation Medicine, Inc.

Verastem, Inc.

Capstone Therapeutics Corp.

LipimetiX Development Inc

LipimetiX Development Inc

The University of Alabama at Birmingham

Connect Biopharma Holdings Ltd.

Connect Biopharma Holdings Ltd.

Arena Pharmaceuticals, Inc.

Cytokinetics, Inc.

National Institutes of Health

US Department of Health and Human Services

Neuropathix, Inc.

US Department of Health and Human Services

Alnylam Pharmaceuticals Inc.

Ascletis Pharma, Inc.

GeneCentric Therapeutics, Inc.

University of North Carolina at Chapel Hill

Curetis N.V.

Mediphos Group BV

Additional Topics

Deals BioPharmaceutical Medical Device

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window